Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

NCT05804032

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Universitätsklinikum Krems Krems, Austria
  • Ordensklinikum Linz Linz, Austria
  • Landeskrankenhaus Feldkirch-Rankweil Rankweil, Austria
  • Universitätsklinikum der Paracelsus, 3. Med. Abteilung/Onkologie Ambulanz Salzburg, Austria
View all 91 locations
View Trial Details
Completed

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

NCT05561751

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • University of Florida (UF) - Shands Cancer Center Gainesville, Florida, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Completed

A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

NCT05014412

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
  • Cancer Care & Hematology - Fort Collins Fort Collins, Colorado, United States
View all 50 locations
View Trial Details
Completed

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

NCT03275285

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • UCSF MS Center Site Number : 8400002 San Francisco, California, United States
  • Spartanburg Medical Center Site Number : 8400003 Spartanburg, South Carolina, United States
  • Investigational Site Number : 0360005 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360006 Tweed Heads, New South Wales, Australia
View all 70 locations
View Trial Details
Completed

A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT04674813

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 005 Birmingham, Alabama, United States
  • Local Institution - 009 Duarte, California, United States
  • Local Institution - 012 San Francisco, California, United States
  • Local Institution - 002 Denver, Colorado, United States
View Trial Details

Related conditions